This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Diagnosis and Pharmacotherapy of Bipolar Depression in Pediatric Patients

Robert L. Findling, MD, MBAa

Published: June 29, 2021

Bipolar depression in youth has a negative effect on numerous domains, including physical and emotional well-being, school and family functioning, friendships, and academic success. Early treatment is crucial, yet diagnosis is difficult. The standard of treatment often requires life-long psychopharmacological management, and most treatments increase risk of adverse effects. Pediatric patients who have at least 1 parent with bipolar disorder are considered to be at higher risk for also developing bipolar depression, although there is currently no clear evidence of efficacious pharmacotherapy for these patients.

See the entire activity

To cite: Findling RL. Diagnosis and pharmacotherapy of bipolar depression in pediatric patients. J Clin Psychiatry. 2021;82(4):SU20014BR2C.
To share:

© Copyright 2021 Physicians Postgraduate Press, Inc.

aVirginia Commonwealth University School of Medicine, Richmond


Volume: 82

Quick Links: Bipolar Disorder , Child and Adolescent , Diagnostic Tools , Psychopharmacology , Side Effects-Medication


Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder

ADHD that persisted into young-adulthood was associated with poorer outcomes in terms of education, employment, and emotional...